Founder, Pritchett Policy Associates
Senior Associate, Center for Strategic & International Studies
Innovation policies, biopharma supply chain, US leadership
The U.S. tech transfer system and the $3.3 trillion in economic output it has generated wouldn’t exist without the Bayh-Dole Act. Read @SallyPipes' piece in @Forbes: